Connect with us

Health

Monkeypox on the Rise in Africa, United States and Europe—WHO

Published

on

birthplace of monkeypox

By Kestér Kenn Klomegâh

With rising cases of Monkeypox, not only in Africa but also in the United States and Europe, the world is now experiencing shivering fears for the next tremendous negative impact similar to Covid-19. It all began the same way, as the first case of Covid-19, and rapidly spread throughout the world. Soon to forget the worldwide border closures, self-isolation and other restrictions.

After documenting more than 7,000 cases in early July, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus has said about the plans on reconvening a meeting of his organization’s Emergency Committee to critically assess the current state of the monkeypox outbreak in Western countries.

Ghebreyesus’s statement implies directing a special focus, considering the current spread and scale of the monkeypox virus outbreak, in Western countries. According to WHO estimation and description or better still categorization, the western countries are “nonendemic” countries.

In his office, Ghebreyesus calculated that more than 7,000 cases have been confirmed in 60 countries so far, with Europe currently the epicentre of the outbreak. Cases began emerging in Europe and the United States in May. Many of the individuals who contracted the virus had travelled internationally. Monkeypox is endemic in some central and western African countries, but Tedros noted that the pathogen was now also being detected in nonendemic African countries.

“My teams are following the data closely. I plan to reconvene the Emergency Committee July 18 or sooner so they are updated on the current epidemiology and evolution of the outbreak, and implementation of counter measures,” he said, Reuters reported.

In June, the WHO’s Emergency Committee said the monkeypox outbreak did not warrant declaring a global health emergency despite the rapid rise in cases. At the time, the health organization said the situation was “unusual” but did not constitute a global health emergency, despite opposing views expressed by some members of the committee.

Health experts, however, referring to official statements that many out of thoughtlessness, have a wide variety of interests to defend and routinely calculate figures, without dealing with the root cause and place of origin. Until today the root cause and place of origin of Covid-19 still remains a mystery.

The recent outbreak has raised cries of double standards from global health activists, who argue that monkeypox has been an ongoing health issue in some African countries for years but is only now garnering sincere attention as it affects Western nations. More than 70 deaths due to monkeypox have been reported in Africa so far this year, while no deaths directly linked to the virus have been confirmed in nonendemic countries.

The WHO has previously acknowledged that monkeypox has been neglected for several years now. Reports, carefully monitored by this author, indicate that the disease is endemic in parts of Africa, where people have become infected through bites from rodents or small animals. The monkeypox virus does not usually spread easily among people. Most monkeypox patients experience fever, body aches, chills and fatigue. People with more serious illnesses may develop a rash and lesions on the face and hands that can spread to other parts of the body.

WHO said it counted 6,027 laboratory-confirmed cases of monkeypox from 59 countries as of the first week of July, an increase of 2,614 cases since its last count that ended June 27. It said three people have now died in connection with the outbreak, all of them in Africa. Most of the cases were reported in Europe and Africa. New cases have also been reported in Ghana and Benin in addition to previously mentioned Cameroon, Central African Republic, Democratic Republic of Congo and Nigeria.

Therefore, WHO should not depend on the continuity of mysterious outbreaks, but go to the roots and take the needed actions. It has, appreciable for now, confined its health recommendations to a standard set of hygienic requirements and did not insist on travel and trade restrictions. Beyond that, it has to establish a task force for keeping high surveillance across the Central and West African region and monitor travellers from these regions.

The Centre for Disease Control (Africa CDC) and the African Society for Laboratory Medicine (ASLM) have jointly held their first training on Real-Time PCR-based Monkeypox virus (MPXV) testing for 20 African Union Member States in Abuja, Nigeria. It was the first in the series of hands-on training on real-time PCR-based monkeypox virus (MPXV) diagnosis launched and organized in partnership with the Nigeria Centre for Disease Control (NCDC) in June.

With Covid-19, China has been alleged or suspected as the country of origin. With Monkeypox Nigeria, the most populated West African nation, has come under the spotlight, allegedly as the place of origin of the monkeypox virus, and was detected in several European countries during the past three months. Besides, Central and West African regions, it’s been detected in external countries namely Spain, Portugal, the United Kingdom, Belgium, Italy, France, Germany, Sweden, Canada, the United States, and Australia.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Lagos Commences Screening of Newborns for Sickle Cell Disease

Published

on

sickle cell disease screening Lagos

By Modupe Gbadeyanka

The Lagos State government has kicked off an initiative to ensure that every newborn is screened for Sickle Cell Disease within 48 to 72 hours after birth using a simple heel-prick test.

It was gathered that babies identified as being at risk will immediately be placed on preventive care while awaiting confirmatory testing.

The Head of the Haematology Department at the Alimosho General Hospital, Dr Olubukola Orolu, revealed that an estimated 150,000 babies are born annually with Sickle Cell Disease in Nigeria, giving the country one of the highest SCD burdens globally.

She, however, applauded the Lagos State Government and the Clinton Health Access Initiative (CHAI) for introducing the state-wide newborn screening programme, describing it as a major step towards reducing childhood deaths associated with the disease.

The commencement of this scheme coincides with the 2026 World Sickle Cell Day, themed Young Voices Rising for Sickle Cell Disease – Closing the Survival Gap: Equity in Sickle Cell Disease.

It highlights the importance of listening to the experiences and aspirations of young people living with Sickle Cell Disease.

Mrs Orolu noted that SCD warriors are increasingly breaking barriers as advocates, leaders, students and change-makers, adding that their voices have continued to reshape the narrative through advocacy for equitable, patient-centred healthcare, self-care and experience sharing.

She, therefore, called for equal access to quality healthcare, survival opportunities and dignity for everyone living with Sickle Cell Disease.

Also commenting, the chief executive of Alimosho General Hospital, Dr Akinyele Akinlade, described Sickle Cell Disease as an inherited blood disorder that is not contagious, noting that individuals living with the condition are more susceptible to infections.

He advised SCD warriors to stay well hydrated, avoid stress, and protect themselves from extreme cold or heat, as these are common triggers of sickle cell crises, adding that these preventive measures can significantly reduce the frequency and severity of crises.

One of the participants, Ms Borokini Zainab, an SCD warrior and student nurse, expressed appreciation to the organisers for the enlightenment programme.

Sharing her personal journey, she spoke about the challenges of balancing recurrent pain crises with her academic pursuits and personal life. Despite moments of frustration, she encouraged fellow warriors not to lose hope.

“Don’t let sickle cell put you down. Be encouraged from within. Don’t let your dreams be shattered because of this,” she said, adding that her personal experience with Sickle Cell Disease inspired her to pursue a career in nursing so she could support others living with the condition.

Continue Reading

Health

Evon Labs Unveils Health-Tech Incubation Initiative HealthX Catalyst

Published

on

Evon Labs Isioma Udeozo HealthX Catalyst

By Aduragbemi Omiyale

A 12-week health-tech incubation programme tailored for early-stage founders in Nigeria has been introduced by an innovation and venture-building platform, Evon Labs.

This initiative, known as HealthX Catalyst, will help participants to create scalable, investable solutions for Africa’s urgent healthcare issues.

The programme is underway, with 12 selected founders nearing the final weeks of intensive incubation, ending with a Demo Day on June 24, 2026, at the UNDP innovation centre in Lagos, where the small business owners will present their solutions to an audience of investors, healthcare leaders, development organisations, and technology partners.

The initiative selects early-stage healthcare founders and immerses them in a structured 12-week development process. Throughout this period, participants receive personalised and group mentorship from seasoned professionals across the healthcare, technology, and business sectors.

They also receive structured support for startup development, including refining business models, developing value propositions, and validating markets.

Additionally, participants gain access to a network of healthcare practitioners, sector experts, and industry leaders, along with targeted investment-readiness assistance to prepare them to engage with investors and strategic partners after the programme.

The result is a cohort of founders who move through the programme not simply with a refined pitch, but with a validated business model, a stronger professional network, and a clear pathway to growth.

To accelerate the most promising solutions beyond the programme, monetary grants will be awarded to the top three founders to support product development, pilot implementation, market validation, and early-stage scaling.

It was learned that HealthX Catalyst was developed in response to a structural gap in the African health-tech ecosystem.

Across the continent, a growing number of entrepreneurs are building solutions to healthcare problems from access and diagnostics to service delivery and health data infrastructure. Yet many of these early-stage ideas fail to progress beyond concept, not for lack of vision, but for lack of structured support: mentorship, startup development frameworks, industry access, and early-stage funding pathways. HealthX Catalyst was built to provide exactly that.

“Africa does not have a shortage of healthcare innovators. What it has lacked is the infrastructure to turn its ideas into sustainable businesses. HealthX Catalyst is that infrastructure, a serious, structured programme designed to take founders from early-stage ideas to investable startups.

“What we are seeing from this first cohort is exactly what we set out to create: founders who are not just building products, but building businesses that can scale and create lasting impact,” the founder of Evon Labs, Ms Isioma Udeozo, said of the unveiling of HealthX Catalyst.

The partners of the programme are the United Nations Development Programme (UNDP), Odua Investment Company Limited (OICL), Washington University of St Louis, Missouri, Lagos State Employment Trust Fund (LSETF), and Brooks Insights.

Continue Reading

Health

Binance Promises $250,000 for Ebola in DR Congo, Uganda

Published

on

Binance

By Aduragbemi Omiyale

The sum of $250,000 in humanitarian funding is to be provided by Binance to support the frontline response to the ongoing Ebola disease outbreak in the Democratic Republic of Congo (DRC) and Uganda.

The cryptocurrency exchange said the funds would be used to enable rapid response in high-risk and underserved areas, where access to healthcare infrastructure, protective resources, and timely public health information remains limited.

The money will be shared equally between the Uganda Red Cross Society and Doctors Without Borders / Médecins Sans Frontières (MSF), supporting urgent interventions in affected and high-risk communities.

Binance’s contribution will help strengthen emergency medical care and treatment, community awareness and prevention campaigns, contact tracing and containment support, and the provision of sanitation supplies and protective equipment for frontline workers.

By supporting both immediate response activities and preventative education, Binance aims to contribute to reducing transmission and strengthening community resilience.

“Communities across Africa continue to show extraordinary resilience in the face of complex challenges, but frontline responders should not have to face crises like this alone,” the co-chief executive of Binance, Mr Richard Teng, said.

“The teams working to contain the Ebola disease outbreak are delivering vital, life-saving support under incredibly difficult conditions.

“We are proud to support both the Uganda Red Cross Society and Doctors Without Borders as they work to protect vulnerable populations, strengthen local response efforts, and deliver urgent care where it is needed most,” he added.

Also commenting, the Secretary General for the Uganda Red Cross Society, Mr Robert Kwesiga, said, “Strong partnerships are essential during public health emergencies since we are not able to manage the outbreak alone.

“The support from Binance comes in so timely and handy, and will help us respond more rapidly, reach more at-risk communities, and reinforce the frontline services needed to help contain the outbreak and save lives.”

The MSF Emergency Programme Manager, Trish Newport, while speaking on the initiative, said, “The number of cases and deaths we are seeing in such a short timeframe, combined with the spread across several health zones and now across the border, is extremely concerning. In Ituri, many people already struggle to access healthcare and live with ongoing insecurity, making rapid action critical to prevent the outbreak from escalating further.”

Caused by the Bundibugyo virus, for which there is no approved vaccine or treatment, this Ebola disease outbreak has placed acute pressure on already fragile health systems in eastern DRC and the wider region.

Local authorities, international agencies, and humanitarian organisations are racing to contain it and protect affected communities.

Binance’s support is intended to reinforce these efforts at a critical moment. It reflects the company’s broader commitment to supporting communities across Africa through programmes focused on education, financial inclusion, digital skills development, and community empowerment.

In this case, Binance is extending that commitment to urgent humanitarian and public health needs by working alongside trusted organisations with deep frontline expertise.

Continue Reading

Trending